CryoPort (NASDAQ: CYRX)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-04 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.220 | -0.310 | -0.0900 | ||||
REV | 52.860M | 52.302M | -558.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of CryoPort (NASDAQ: CYRX) through any online brokerage.
Other companies in CryoPort’s space includes: Natus Medical (NASDAQ:NTUS), Heska (NASDAQ:HSKA), Varex Imaging (NASDAQ:VREX), AngioDynamics (NASDAQ:ANGO) and Inari Medical (NASDAQ:NARI).
The latest price target for CryoPort (NASDAQ: CYRX) was reported by Needham on Friday, May 6, 2022. The analyst firm set a price target for 41.00 expecting CYRX to rise to within 12 months (a possible 31.79% upside). 13 analyst firms have reported ratings in the last year.
The stock price for CryoPort (NASDAQ: CYRX) is $31.11 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for CryoPort.
CryoPort’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for CryoPort.
CryoPort is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.